THE INFLUENCE OF VITAMIN D RECEPTOR GEN 283 A>G (BSMI) POLYMORPHISM ON OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
https://doi.org/10.21886/2219-8075-2016-4-32-38
Abstract
About the Author
E. A. MaylyanUkraine
16 Illicha Ave., Donetsk 283003, DPR
References
1. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R., Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1): 23–57. doi: 10.1007/s00198-012-2074-y.
2. Barlow DH, Bouchard P, Brandi ML, Evers JL, Glasier A, Negri E, et al. Bone fractures after menopause. Hum. Reprod. Update. 2010;16(6):761-773. doi: 10.1093/humupd/dmq008.
3. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143-156. doi: 10.1016/j.gene.2004.05.014.
4. Jia F, Sun RF, Li QH, Wang DX, Zha F, Li JM, et al. Vitamin D Receptor BsmI Polymorphism and Osteoporosis Risk: A Meta-Analysis from 26 Studies. Genetic Testing and Molecular Biomarkers. 2013;17(1):30–34. doi: 10.1089/gtmb.2012.0267.
5. Li Y, Xi B, Li K, Wang C. Association between vitamin D receptor gene polymorphisms and bone mineral density in Chinese women. Mol. Biol. Rep. 2012;39(5):5709-5717. doi: 10.1007/ s11033-011-1380-3.
6. Mohammadi Z, Fayyazbakhsh F, Ebrahimi M, Amoli MM, Khashayar P, Dini M, et al. Association between vitamin D receptor gene polymorphisms (Fok1 and Bsm1) and osteoporosis: a systematic review. J. Diabetes Metab. Disord. 2014;13:98. doi: 10.1186/s40200-014-0098-x/. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215021/. Accessed on October 1, 2016.
7. Qin G, Dong Z, Zeng P, Liu M, Liao X. Association of vitamin D receptor BsmI gene polymorphism with risk of osteoporosis: a meta-analysis of 41 studies. Mol. Biol. Rep. 2013;40(1):497-506. doi: 10.1007/s11033-012-2086-x.
8. Zhao B, Zhang W, Du S, Zhou Z. Vitamin D receptor BsmI polymorphism and osteoporosis risk in post-menopausal women. Arch. Med. Sci. 2016;12(1):25–30. doi: 10.5114/aoms.2016.57475.
9. Myakotkin VA, Krylov MY, Guseva IA, Chetina EV, Toroptsova NV, Nikitinskaya OA, et al. Molecular Genetic Testing of Osteoporosis Susceptibility in Postmenopusal Women in Moscow. Rheumatology Science and Practice. 2011;49(2):15-20. doi:10.14412/1995-4484-2011-597. (In Russ.).
10. Povoroznyk VV, Balatska NI, Klimovitsky FV. Relationship between Polymorphism of Gene Receptor of Vitamin D and Structural-functional State of Bone Tissue. Vestnik ortopedii, travmatologii i protezirovanija. 2013;1:34–37. (In Ukr.).
11. Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169(4):505-514. doi: 10.1093/aje/kwn359.
12. Kazimirko VK, Kovalenko VN, Flegontova VV. Involutionary osteoarthritis and osteoporosis. Doneck: Izdatel’ Zaslavskij A.Ju; 2011. (In Russ).
13. Urano T, Inoue S. Genetics of osteoporosis. Biochem. Biophys. Res. Commun. 2014;452(2):287-293. doi: 10.1016/j.bbrc.2014.07.141.
14. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(15):6665-6669.
Review
For citations:
Maylyan E.A. THE INFLUENCE OF VITAMIN D RECEPTOR GEN 283 A>G (BSMI) POLYMORPHISM ON OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN. Medical Herald of the South of Russia. 2016;(4):32-38. (In Russ.) https://doi.org/10.21886/2219-8075-2016-4-32-38